Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy

scientific article published on 10 July 2015

Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1030363254
P356DOI10.1186/S13014-015-0436-2
P932PMC publication ID4496940
P698PubMed publication ID26159409
P5875ResearchGate publication ID279989362

P50authorSuvi Sirkku TuohinenQ57613905
P2093author name stringPirkko-Liisa Kellokumpu-Lehtinen
Pekka Raatikainen
Vesa Virtanen
Eeva Boman
Tanja Skyttä
P2860cites workHeart failure with preserved ejection fraction: mechanisms, clinical features, and therapiesQ27000263
Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatmentQ31123683
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapyQ33183838
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trialsQ34054354
Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancerQ34118122
Enhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesisQ34602939
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomesQ35925266
Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancerQ36032531
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerQ36637777
Early detection and prediction of cardiotoxicity in chemotherapy-treated patientsQ36988282
European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studiesQ37200104
Heart failure with preserved ejection fraction in the elderly: scope of the problemQ37633991
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of EchocardiographyQ38133653
Outcomes in patients with heart failure with preserved ejection fractionQ38224336
Heart failure with preserved ejection fraction: Defining the function of ROS and NO.Q38482322
Risk of ischemic heart disease in women after radiotherapy for breast cancerQ43615460
Evaluation of cardiotoxicity via speckle-tracking echocardiography in patients treated with anthracyclinesQ43840614
Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays.Q46125897
Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in ratsQ46754121
Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers?Q48229693
Early detection of epirubicin-induced cardiotoxicity in patients with breast cancerQ48703366
High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptideQ48917080
Serum levels of high-sensitivity troponin T: a novel marker for left ventricular remodeling and performance in hypertensive subjects.Q51318301
N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer.Q53221109
Subclinical cardiac dysfunction detected by strain imaging during breast irradiation with persistent changes 6 weeks after treatment.Q53508184
The incidence and functional consequences of RT-associated cardiac perfusion defects.Q53573289
Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution.Q53657880
Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls.Q53855288
Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association?Q54596767
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.Q54702884
Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection FractionQ57315206
Serum cardiac troponin T levels during treatment of early-stage breast cancerQ71832948
Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective studyQ71875608
Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in ratsQ80458516
Long-term cardiovascular mortality after radiotherapy for breast cancerQ83251863
Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periodsQ83964012
Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy populationQ84977707
Mechanisms and dose-response relationships for radiation-induced cardiovascular diseaseQ85249480
Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapyQ85424948
Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular riskQ87264249
Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failureQ87607038
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P304page(s)141
P577publication date2015-07-10
P1433published inRadiation OncologyQ2313370
P1476titleTroponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy
P478volume10

Reverse relations

cites work (P2860)
Q92073283Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy
Q92120577BNP as a potential biomarker for cardiac damage of breast cancer after radiotherapy: a meta-analysis
Q88868148Biomarker Discovery in Cardio-Oncology
Q61454620Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity
Q45040846Biomarkers of cardiac injury in patients undergoing thoracic radiation therapy
Q98154746Biomarkers of radiation-induced vascular injury
Q30251498Cancer drug related cardiotoxicity during breast cancer treatment
Q50045986Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
Q57811270Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer
Q90478154Detection of radiation induced cardiotoxicity: Role of echocardiography and biomarkers
Q93175092Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma
Q36774819Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Q92440937Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer
Q39029699Effects of ionizing radiation on the heart
Q47757777Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer
Q57477384Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention
Q47772072High sensitivity troponins in contemporary cardiology practice: are we turning a corner?
Q88683757How to prevent and manage radiation-induced coronary artery disease
Q50894688Infundibular pulmonary stenosis after radiotherapy for breast cancer.
Q28071302Novel concepts in radiation-induced cardiovascular disease.
Q94547024Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
Q89521140Radiation and cardiovascular disease
Q39185680Radiation-Induced Cardiovascular Disease
Q45072741Radiation-Induced Cardiovascular Disease: A Clinical Perspective
Q90047697Relationship Between Changes in Myocardial F-18 Fluorodeoxyglucose Uptake and Radiation Dose After Adjuvant Three-Dimensional Conformal Radiotherapy in Patients with Breast Cancer
Q55429574Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment.

Search more.